KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Net Cash Flow (2017 - 2025)

Historic Net Cash Flow for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to $328762.0.

  • Co-Diagnostics' Net Cash Flow rose 11073.95% to $328762.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $542399.0, marking a year-over-year decrease of 274.92%. This contributed to the annual value of -$12.0 million for FY2024, which is 4869.61% down from last year.
  • Per Co-Diagnostics' latest filing, its Net Cash Flow stood at $328762.0 for Q3 2025, which was up 11073.95% from $9.2 million recorded in Q2 2025.
  • In the past 5 years, Co-Diagnostics' Net Cash Flow registered a high of $14.8 million during Q1 2021, and its lowest value of -$58.5 million during Q4 2022.
  • In the last 5 years, Co-Diagnostics' Net Cash Flow had a median value of $328762.0 in 2025 and averaged -$1.7 million.
  • As far as peak fluctuations go, Co-Diagnostics' Net Cash Flow soared by 95706.86% in 2021, and later tumbled by 108393.54% in 2022.
  • Quarter analysis of 5 years shows Co-Diagnostics' Net Cash Flow stood at $5.9 million in 2021, then crashed by 1083.94% to -$58.5 million in 2022, then surged by 107.99% to $4.7 million in 2023, then tumbled by 270.3% to -$8.0 million in 2024, then skyrocketed by 104.13% to $328762.0 in 2025.
  • Its last three reported values are $328762.0 in Q3 2025, $9.2 million for Q2 2025, and -$1.0 million during Q1 2025.